<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">92469</article-id>
<article-id pub-id-type="doi">10.7554/eLife.92469</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92469.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of femoral head</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5987-4146</contrib-id>
<name>
<surname>Xia</surname>
<given-names>Chenjie</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">*</xref></contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Xu</surname>
<given-names>Huihui</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n1">*</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Fang</surname>
<given-names>Liang</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jiali</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Wenhua</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Danqing</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xucheng</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Bangjian</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Luwei</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Chengliang</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tong</surname>
<given-names>Peijian</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4258-3457</contrib-id>
<name>
<surname>Chen</surname>
<given-names>Di</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
<xref ref-type="corresp" rid="cor1">†</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Pinger</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">†</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8795-0874</contrib-id>
<name>
<surname>Jin</surname>
<given-names>Hongting</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">†</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Institute of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine</institution>, Hangzhou, Zhejiang 310053, <country>China</country></aff>
<aff id="a2"><label>2</label><institution>Department of Orthopedic Surgery, the Affiliated Lihuili Hospital of Ningbo University</institution>, Ningbo, Zhejiang 315040, <country>China</country></aff>
<aff id="a3"><label>3</label><institution>The First College of Clinical Medicine, Zhejiang Chinese Medical University</institution>, Hangzhou, Zhejiang 310053, <country>China</country></aff>
<aff id="a4"><label>4</label><institution>School of Basic Medical Sciences, Zhejiang Chinese Medical University</institution>, Hangzhou, Zhejiang 310053, <country>China</country></aff>
<aff id="a5"><label>5</label><institution>Department of Orthopedic Surgery, the First Affiliated Hospital of Zhejiang Chinese Medical University</institution>, Hangzhou, Zhejiang 310003, <country>China</country></aff>
<aff id="a6"><label>6</label><institution>Faculty of Pharmaceutical Sciences, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences</institution>, Shenzhen 518055, <country>China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ji</surname>
<given-names>Yaoting</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Wuhan University</institution>
</institution-wrap>
<city>Wuhan</city>
<country>China</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Weigel</surname>
<given-names>Detlef</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Max Planck Institute for Biology Tübingen</institution>
</institution-wrap>
<city>Tübingen</city>
<country>Germany</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>†</label>Corresponding author: Di Chen, Faculty of Pharmaceutical Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068, Xueyuan Road, Shenzhen 518055, China, Email: <email>di.chen@siat.ac.cn</email>; Ping-er Wang, Institute of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548, Binwen Road, Hangzhou, Zhejiang Province 310053, China, Email: <email>pingerwang@zcmu.edu.cn</email>; Hongting Jin, Institute of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548, Binwen Road, Hangzhou, Zhejiang Province 310053, China. Email: <email>hongtingjin@zcmu.edu.cn</email></corresp>
<fn id="n1" fn-type="equal"><label>*</label><p>These authors have an equal contribution to this work.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-11-01">
<day>01</day>
<month>11</month>
<year>2023</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2024-01-24">
<day>24</day>
<month>01</month>
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP92469</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-09-20">
<day>20</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-10-06">
<day>06</day>
<month>10</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.10.04.560853"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2023-11-01">
<day>01</day>
<month>11</month>
<year>2023</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92469.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.92469.1.sa3">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.92469.1.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.92469.1.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.92469.1.sa0">Reviewer #3 (Public Review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Xia et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Xia et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-92469-v2.pdf"/>
<abstract>
<title>Abstract</title><p>Glucocorticoid-induced osteonecrosis of the femoral head (GONFH) is a common refractory joint disease characterized by bone damage and the collapse of femoral head structure. However, the exact pathological mechanisms of GONFH remain unknown. Here, we observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients. In vivo and in vitro studies further revealed that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation of bone marrow mesenchymal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats. Col2<sup>+</sup> lineage largely contributes to BMSCs, and was found an osteogenic commitment in the femoral head through 9 months of lineage trace. Specific deletion of <italic>β-catenin</italic> in Col2<sup>+</sup> cells shifted their commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice. Overall, we uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of GONFH, and identify an ideal genetic modified mouse model of GONFH.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Glucocorticoid</kwd>
<kwd>Osteonecrosis of the femoral head</kwd>
<kwd>β-catenin</kwd>
<kwd>Osteogenic/adipogenic differentiation</kwd>
<kwd>Col2<sup>+</sup> lineage</kwd>
</kwd-group>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>We have added the labels of beta-catenin, ALP and FABP4 below the X axis in Fig. 2H; We have provided the quantitative bar graph in Fig. 1I; provided more information of experiment procedures; listed the limitions of the present study.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Glucocorticoids, potent immunity regulators, are widely used in the treatment of various autoimmune diseases such as systemic lupus erythematosus (SLE), nephrotic syndrome (NS) and rheumatoid arthritis (RA)<sup>[<xref ref-type="bibr" rid="c1">1</xref>]</sup>. However, excessive usage of glucocorticoids has been reported to cause severe adverse effects, especially femoral head osteonecrosis in the joint<sup>[<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c3">3</xref>]</sup>. As a destructive joint disease, glucocorticoid-induced osteonecrosis of the femoral head (GONFH) disables about 100,000 Chinese and more than 20,000 Americans annually<sup>[<xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c5">5</xref>]</sup>, bringing a huge financial burden on the society. Currently, there is no ideal medical treatment for GONFH due to its unclear pathological mechanisms. Most patients eventually have to undergo a joint replacement surgery<sup>[<xref ref-type="bibr" rid="c6">6</xref>]</sup>. Therefore, in-depth study of GONFH pathogenesis is urgently needed.</p>
<p>Previous <italic>ex-vivo</italic> studies on human necrotic femoral heads revealed prominent pathological features of GONFH including fat droplet clusters, trabecular bone loss, empty lacunae of osteocyte at the early stage and extra subchondral bone destruction, structure collapse at the late stage<sup>[<xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>]</sup>. Glucocorticoid-induced animal models are commonly used to study GONFH pathogenesis, which mimic the early necrotic changes of GONFH but without structure collapse<sup>[<xref ref-type="bibr" rid="c9">9</xref>]</sup>. Several hypotheses, such as damaged blood supply<sup>[<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c11">11</xref>]</sup>, abnormal lipid metabolism<sup>[<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c13">13</xref>]</sup> and bone cell apoptosis<sup>[<xref ref-type="bibr" rid="c14">14</xref>, <xref ref-type="bibr" rid="c15">15</xref>]</sup> have been proposed to explain the occurrence and development of GONFH. However, the therapies developed according to the guideline established based on these theories have not been successful in prevention of GONFH progression. Clinical evidence about decreased replication and osteogenic differentiation capacity of bone marrow mesenchymal stromal cells (BMSCs)<sup>[<xref ref-type="bibr" rid="c16">16</xref>–<xref ref-type="bibr" rid="c18">18</xref>]</sup> and the efficacy of BMSCs transplantation<sup>[<xref ref-type="bibr" rid="c19">19</xref>–<xref ref-type="bibr" rid="c21">21</xref>]</sup> in GONFH patients indicate that GONFH might be a BMSCs-related disease. BMSCs contain mesenchymal progenitor cells which give rise to osteoblasts and adipocytes, and glucocorticoids have been shown to regulate osteogenic/adipogenic differentiation of BMSCs <italic>in vitro</italic><sup>[<xref ref-type="bibr" rid="c22">22</xref>, <xref ref-type="bibr" rid="c23">23</xref>]</sup>. Various treatments targeting on promoting osteogenic differentiation of BMSCs alleviate early necrotic phenotype in glucocorticoid-induced GONFH animal models<sup>[<xref ref-type="bibr" rid="c24">24</xref>–<xref ref-type="bibr" rid="c26">26</xref>]</sup>. Thus, we hypothesize that imbalanced osteogenic/adipogenic differentiation of BMSCs plays a dominant role in GONFH pathogenesis. Recent lineage tracing and single-cell RNA sequencing studies revealed that BMSCs are a group of heterogeneous multipotent cells<sup>[<xref ref-type="bibr" rid="c27">27</xref>]</sup>, and skeletal-derived mesenchymal progenitor cells including collagen II (Col2)<sup>+</sup> lineage and Osterix (Osx)<sup>+</sup> lineage compose a large proportion of BMSCs<sup>[<xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c29">29</xref>]</sup>. However, which sub-population of BMSCs significantly contributes to the GONFH pathogenesis remains unknown.</p>
<p>BMSCs differentiation is a complex process and is regulated by multiple signaling pathways. Among them, canonical Wnt/β-catenin signaling functions as a switch in determining osteogenic/adipogenic differentiation of BMSCs<sup>[<xref ref-type="bibr" rid="c30">30</xref>]</sup>. When β-catenin is accumulated in the nucleus, interacting with TCF/Lef transcription factors to activate downstream target genes including Runt-related transcription factor 2 (Runx2) and Osterix<sup>[<xref ref-type="bibr" rid="c31">31</xref>]</sup>. On the contrary, inhibition of β-catenin induces expressions of CCAAT/enhancer binding protein alpha (C/EBPα) and peroxisome proliferator activated receptor gamma (PPAR-γ) for adipogenesis<sup>[<xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c33">33</xref>]</sup>. Our previous study showed a significant decrease of β-catenin in the glucocorticoid-induced GONFH rat model<sup>[<xref ref-type="bibr" rid="c34">34</xref>]</sup>. Other groups also reported an involvement of β-catenin signaling in GONFH development<sup>[<xref ref-type="bibr" rid="c35">35</xref>–<xref ref-type="bibr" rid="c39">39</xref>]</sup>.</p>
<p>Here, abnormal osteogenesis and adipogenesis with decreased β-catenin signaling were observed in the necrotic femoral heads of GONFH patients and glucocorticoid-induced GONFH rats. Activation of β-catenin signaling effectively alleviated the necrotic changes in GONFH rats by restoring glucocorticoid exposure-induced imbalanced osteogenic/adipogenic differentiation of BMSCs. Interestingly, specific deletion of <italic>β-catenin</italic> in Col2<sup>+</sup> cells, but not Osx<sup>+</sup> cells led to a full spectrum of disease phenotype of GONFH in mice even including subchondral bone destruction and femoral head collapse. Our present study provided novel molecular mechanisms of GONFH pathogenesis, and an ideal genetic modified mouse model for GONFH study.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Abnormal osteogenesis and adipogenesis with decreased β-catenin in necrotic femoral heads of GONFH patients</title>
<p>To determine the pathogenesis of GONFH, we harvested the surgical specimens from GONFH patients with femoral head necrosis (n=15) and samples from trauma patients without femoral head necrosis (n=10). Compared to the non-necrotic femoral heads, we observed subchondral bone destruction (<xref rid="fig1" ref-type="fig">Figure 1A</xref>, black asterisk), liquefied necrotic foci (<xref rid="fig1" ref-type="fig">Figure 1A</xref>, black arrow), deformed and collapsed outline in the necrotic femoral head. μCT analysis further showed sparse and cracked trabeculae in the collapsed region (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, red box) and liquefied necrotic region (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, yellow box) compared to the corresponding regions (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, white boxes) in the non-necrotic femoral heads, which were further confirmed by the decreased BV/TV, Tb.N and Tb.Th and increased Tb.Sp (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). The representative images of ABH staining (<xref rid="fig1" ref-type="fig">Figure 1D</xref>) revealed sparse trabeculae, massive accumulated fat droplets (<xref rid="fig1" ref-type="fig">Figure 1D</xref>, black triangles), numerous empty lacunae of osteocytes (<xref rid="fig1" ref-type="fig">Figure 1D</xref>, black arrows) and extensive subchondral bone destruction (<xref rid="fig1" ref-type="fig">Figure 1D</xref>, yellow arrows) in the necrotic femoral heads. Histomorphological quantitative analyses showed decreased trabecular bone area (<xref rid="fig1" ref-type="fig">Figure 1E</xref>), increased fat droplet area (<xref rid="fig1" ref-type="fig">Figure 1E</xref>) and empty lacunae rate (<xref rid="fig1" ref-type="fig">Figure 1F</xref>) in the necrotic femoral heads. TUNEL staining revealed more apoptotic osteocytes in the necrotic femoral heads (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). We then detected the expression of osteogenic (Runx2, Osterix) and adipogenic (FABP4, PPAR-γ, CEBP/α) marker genes. The results of IHC staining showed a down-regulation of Runx2 and an up-regulation of FABP4 in the necrotic regions (<xref rid="fig1" ref-type="fig">Figure 1H</xref>). Western blot analysis showed increased expressions of PPAR-γ and CEBP/α and a decreased expression of Osterix in the human necrotic femoral head tissues (<xref rid="fig1" ref-type="fig">Figure 1I</xref>). These findings indicate an involvement of abnormal osteogenesis and adipogenesis during GONFH pathogenesis. β-catenin can regulate osteogenesis and adipogenesis downstream target genes (Runx2, Osterix, FABP4, PPAR-γ and CEBP/α) expressions<sup>[<xref ref-type="bibr" rid="c40">40</xref>]</sup>. The significant decrease of β-catenin in the necrotic femoral heads (<xref rid="fig1" ref-type="fig">Figure 1G</xref>, <xref rid="fig1" ref-type="fig">1H</xref>) indicate an important role of β-catenin signaling in GONFH pathogenesis.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><p>Abnormal osteogenesis and adipogenesis with decreased β-catenin signaling in the necrotic femoral heads of GONFH patients. Necrotic (n=15) and Non-necrotic (n=10) femoral head samples were obtained from the patients with GONFH or femoral neck fracture, respectively. (A) Gross anatomy analysis of human necrotic and non-necrotic femoral head samples. Black asterisks: subchondral collapsed region. Black arrows: liquefied necrotic region. (B) μCT images of human necrotic and non-necrotic femoral heads. Red and Yellow boxed area: 3D images of subchondral collapsed region and liquefied necrotic region, respectively. White boxed areas: 3D images of corresponding regions in the non-necrotic femoral heads. (C) Quantitative analysis of BV/TV, Tb.N, Tb.Th and Tb.Sp on the necrotic regions. (D) ABH staining of human necrotic and non-necrotic femoral heads. a,c: high magnification images of bone marrow; b,d: high magnification images of bone trabeculae; Yellow arrows: subchondral bone destruction; black arrows: empty lacunae of osteocytes; black triangles: fat droplets. (E) Histomorphological quantitative analysis of trabecular bone area and fat droplet area. (F) Histomorphological quantitative analysis of empty lacunae rate. (G) TUNEL staining of osteocytes in human necrotic and non-necrotic femoral heads. (H) IHC staining of Runx2 and FABP4 expressions in human necrotic and non-necrotic femoral heads. (I) Western blot of β-catenin, Osterix, PPAR-γ and CEBP/α in human necrotic and non-necrotic femoral heads.</p></caption>
<graphic xlink:href="560853v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Inhibition of β-catenin signialing leads to abnormal osteogenesis and adipogenesis in glucocorticoid-induced GONFH rats</title>
<p>To further analyze the role of β-catenin in GONFH pathogenesis, a glucocorticoid-induced GONFH rat model was established by continuous MPS induction, as previously described<sup>[<xref ref-type="bibr" rid="c9">9</xref>]</sup>. Gross anatomy analysis showed a local melanocratic region on the femoral head surface of GONFH rats without any structure deformity or collapse (<xref rid="fig2" ref-type="fig">Figure 2A</xref>, black arrow). No color change was observed on the femoral head surface from the Wnt agonist 1 treated rats. μCT images and quantitative analysis of bone microstructure showed severe trabecular bone loss in the femoral heads of GONFH rats, especially in the subchondral region (<xref rid="fig2" ref-type="fig">Figure 2A</xref>, <xref rid="fig2" ref-type="fig">2B</xref>). Systemic injection of Wnt agonist 1 effectively increased bone mass (<xref rid="fig2" ref-type="fig">Figure 2A</xref>), and alleviated decreased BV/TV, Tb.N and Tb.Th and increased Tb.Sp in GONFH rats (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). ABH staining and histomorphological quantitative analysis revealed that the GONFH rats presented sparse trabeculae, massive fat accumulation (<xref rid="fig2" ref-type="fig">Figure 2C</xref>, black arrow) and numerous empty lacunae of osteocytes (<xref rid="fig2" ref-type="fig">Figure 2C</xref>, black arrows) in the necrotic region of femoral heads (<xref rid="fig2" ref-type="fig">Figure 2C</xref>-<xref rid="fig2" ref-type="fig">2E</xref>). However, no subchondral bone destruction, femoral head collapse and deformity was occurred in this GONFH rat model (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). TUNEL staining revealed increased apoptotic osteocytes in the femoral heads of GONFH rats (<xref rid="fig2" ref-type="fig">Figure 2F</xref>). ALP is an osteoblast marker reflecting the capacity of osteogenesis. FABP4 is essential for lipid formation and metabolism. The decreased β-catenin and ALP expressions and increased FABP4 expression confirmed abnormal osteogenesis and adipogenesis during rat GONFH development (<xref rid="fig2" ref-type="fig">Figure 2G</xref>, <xref rid="fig2" ref-type="fig">2H</xref>), consistent with the findings in human GONFH femoral heads. Interestingly, activation of β-catenin by systematically injecting Wnt agonist 1 for 6 weeks attenuated the early necrotic changes (<xref rid="fig2" ref-type="fig">Figure 2C</xref>-<xref rid="fig2" ref-type="fig">2E</xref>) and osteocyte apoptosis (<xref rid="fig2" ref-type="fig">Figure 2F</xref>), and restored ALP and FABP4 expressions in the femoral heads of GONFH rats (<xref rid="fig2" ref-type="fig">Figure 2G</xref>, <xref rid="fig2" ref-type="fig">2H</xref>). Overall, these data indicate that β-catenin inhibition-induced abnormal osteogenesis and adipogenesis contributes to GONFH pathogenesis.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><p>Systemic injection of Wnt agonist 1 alleviates abnormal osteogenesis and adipogenesis in rat GONFH femoral heads. The rat model of GONFH was established by a co-induction of lipopolysaccharide and methylprednisolone (MPS). The femoral head samples were harvested after GONFH rats were intravenously injected with Wnt agonist 1 for 6 weeks. (A) Gross anatomy analysis and μCT images of femoral heads in sham, model and Wnt agonist 1 treated groups. (B) μCT quantitative analysis of BV/TV, Tb.N, Tb.Th and Tb.Sp in each group. (C) ABH staining of femoral heads in each group. a-c, high magnification images of the representative region; black arrows: empty lacunae of osteocytes; black triangles: fat droplets. (D) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in each group. (E) Histomorphological quantitative analysis of empty lacunae rate in each group. (F) TUNEL staining of osteocytes in the femoral heads of GONFH rats. (G, H) IHC staining and quantitative analysis of β-catenin, ALP and FABP4 in rat femoral heads of each group.</p></caption>
<graphic xlink:href="560853v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2c">
<title>β-catenin directs dexamethasone-induced osteogenic/adipogenic differentiation of rat BMSCs</title>
<p>We further investigated cellular mechanisms involved in the necrotic femoral heads of glucocorticoid-induced GONFH rats. Primary bone marrow cells were extracted from the proximal femur of 4-week-old SD rats and cultivated to P3. Flow cytometry analysis identified that they were BMSCs, with CD90<sup>+</sup>, CD29<sup>+</sup>, CD45<sup>−</sup> and CD11b<sup>−</sup> characteristics (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). ALP staining showed that the osteogenic differentiation of BMSCs were significantly inhibited after exposing to 10<sup>2</sup> nM or higher concentration of Dex for 7 days (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). Oil red O staining showed a progressive adipogenic differentiation of BMSCs with the increased concentration of Dex (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). These findings indicated that increased adipogenic differentiation and decreased osteogenic differentiation of BMSCs caused the abnormal osteogenesis and adipogenesis, finally leading to the femoral head necrosis in GONFH rats. The decreased expressions of β-catenin, Runx2, ALP and increased expressions of PPAR-γ, CEBP/α further revealed that Dex exposure inhibited β-catenin signaling, and redirected BMSCs differentiation from osteoblasts to adipocytes (<xref rid="fig3" ref-type="fig">Figure 3C</xref>, <xref rid="fig3" ref-type="fig">3D</xref>). However, this Dex-induced abnormal differentiation of BMSCs were restored by SKL2001 through activation of β-catenin signaling (<xref rid="fig3" ref-type="fig">Figure 3E</xref>-<xref rid="fig3" ref-type="fig">3G</xref>). Taken together, these findings suggest that β-catenin inhibition redirects the direction of BMSCs differentiation, contributing to the GONFH development.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><p>Activation of β-catenin redirected Dex-induced imbalanced osteogenic/adipogenic differentiation of BMSCs. Primary BMSCs were extracted from the proximal femur of 4-week-old SD rats and cultivated to passage 3 for subsequent experiments. (A) Flow cytometry analyzing the surface markers of rat BMSCs. (B) ALP staining and oil red O staining of BMSCs at the increasing concentrations of dexamethasone (Dex). (C, D) Western blot and quantitative analysis of β-catenin, Runx2, ALP, PPAR-γ and CEBP/α in BMSCs at the increasing concentrations of Dex. (E) ALP staining and oil red O staining of rat BMSCs at the condition with or without 10<sup>4</sup> nM Dex and 20 μM SKL2001 (an agonist of β-catenin). (F, G) Western blot and quantitative analysis of β-catenin, Runx2, ALP, PPAR-γ and CEBP/α in rat BMSCs at the condition with or without 10<sup>4</sup> nM Dex and 20 μM SKL2001.</p></caption>
<graphic xlink:href="560853v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>Loss-of-function of β-catenin in Col2<sup>+</sup>, but not Osx<sup>+</sup>, -expressing cells leads to a GONFH-like phenotype in femoral head</title>
<p>Skeletal progenitor cells are major source of BMSCs, and both Col2<sup>+</sup> lineage and Osx<sup>+</sup> lineage can trans-differentiate into BMSCs<sup>[<xref ref-type="bibr" rid="c27">27</xref>, <xref ref-type="bibr" rid="c28">28</xref>]</sup>. To determine which subset of BMSCs contributes more to GONFH pathogenesis, we generated <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>β-catenin<sup>OsxER</sup></italic> mice, in which <italic>β-catenin</italic> gene was specifically deleted in Col2<sup>+</sup> cells and Osx<sup>+</sup> cells, respectively. For mapping their cell fate in the femoral head, we induced <italic>Tomato<sup>Col2ER</sup></italic> mice and <italic>Tomato<sup>OsxER</sup></italic> mice at 2-weeks old and analyzed at the age of 1 month. The fluorescent images showed that Col2<sup>+</sup> cells were evidently expressed in the chondrocytes of articular cartilage, secondary ossification center and growth plate (<xref rid="fig4" ref-type="fig">Figure 4A</xref>, white arrowheads), osteoblasts (<xref rid="fig4" ref-type="fig">Figure 4A</xref>, green arrowheads), osteocytes (<xref rid="fig4" ref-type="fig">Figure 4A</xref>, yellow arrowheads) and stromal cells (<xref rid="fig4" ref-type="fig">Figure 4A</xref>, red arrowheads) underneath the growth plate, while Osx<sup>+</sup> cells were identified only in osteoblasts, osteocytes and stromal cells underneath the growth plate (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). We then trace Col2<sup>+</sup> lineage for 9 months and found that Col2<sup>+</sup> chondrocytes in secondary ossification center and growth plate were replaced by Col2<sup>+</sup> osteoblasts, osteocytes and stromal cells with age (<xref rid="fig4" ref-type="fig">Figure 4B</xref>), and these Col2<sup>+</sup> cells continuously produced osteoblasts and osteocytes in the femoral head (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). These findings indicated the self-renew ability and osteogenic commitment of Col2<sup>+</sup> cells. We also induced <italic>Tomato<sup>Col2ER</sup></italic> mice at the age of 1 month, but identified a poor <italic>Cre</italic>-recombinase efficiency 24 hours and 3 months later (<xref rid="fig4" ref-type="fig">Figure 4C</xref>). IHC assay showed a significant decrease of β-catenin in the femoral heads of 3-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>β-catenin<sup>OsxER</sup></italic> mice (<xref rid="fig4" ref-type="fig">Figure 4D</xref>, <xref rid="fig4" ref-type="fig">4E</xref>), indicating successful establishments of these <italic>β-catenin</italic> conditional knockout mouse models.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><p>Fate mapping of Col2<sup>+</sup> cells and Osx<sup>+</sup> cells in the femoral head. <italic>Tomato<sup>Col2ER</sup></italic> mice and <italic>Tomato<sup>OsxER</sup></italic> mice were continuously received 5 dose of TM injections (1 mg/10 g body weight) at the age of 2 weeks for fate mapping analysis. (A) Distributions of Col2<sup>+</sup> and Osx<sup>+</sup> cells in the femoral heads of 1-month-old <italic>Tomato<sup>Col2ER</sup></italic> mice and <italic>Tomato<sup>OsxER</sup></italic>mice. White arrowheads: chondrocytes; Green arrowheads: osteoblasts; Yellow arrowheads: osteocytes; Red arrowheads: bone marrow stromal cells; GP: growth plate; SOC: second ossification center; BM: bone marrow. (B) Lineage trace of Col2<sup>+</sup> cells in the femoral head for 9 months. a: high magnification image of bone marrow region. (C) Poor <italic>Cre</italic>-recombinase efficiency in the femoral heads of <italic>Tomato<sup>Col2ER</sup></italic> mice with TM induction at the age of 1 month. (D, E) Femoral heads were harvested from 3-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>β-catenin<sup>OsxER</sup></italic> mice to detect expression of βLcatenin. IHC staining and quantitative analysis of β-catenin in the femoral heads of 3-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>β-catenin<sup>OsxER</sup></italic> mice.</p></caption>
<graphic xlink:href="560853v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Then, we analyzed morphologic changes of the femoral heads from 3-months old <italic>β-catenin<sup>Col2ER</sup></italic>mice and <italic>β-catenin<sup>OsxER</sup></italic>mice. No change of appearance was observed on the femoral heads both in <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>β-catenin<sup>OsxER</sup></italic>mice compared to <italic>Cre</italic>-negative littermates (<xref rid="fig5" ref-type="fig">Figure 5A</xref>, <xref rid="fig6" ref-type="fig">6A</xref>). μCT images and quantitative analysis of decreased BV/TV, Tb.N, Tb.Th and increased Tb.Sp indicated that both <italic>β-catenin<sup>Col2ER</sup></italic>mice and <italic>β-catenin<sup>OsxER</sup></italic>mice presented severe bone loss in the femoral heads (<xref rid="fig5" ref-type="fig">Figure 5B</xref>, <xref rid="fig6" ref-type="fig">6B</xref>). ABH staining and histomorphological analysis further revealed that bone trabeculae were extensively replaced by fat droplet clusters in the femoral heads (especially in the subchondral region) of <italic>β-catenin<sup>Col2ER</sup></italic> mice (<xref rid="fig5" ref-type="fig">Figure 5C</xref>, <xref rid="fig5" ref-type="fig">5D</xref>), similar to the necrotic femoral heads in GONFH patients and glucocorticoid-induced rat models. However, no fat droplet accumulation but only sparse and thin bone trabeculae were observed in the femoral heads of <italic>β-catenin<sup>OsxER</sup></italic>mice (<xref rid="fig6" ref-type="fig">Figure 6C</xref>, <xref rid="fig6" ref-type="fig">6D</xref>). Compared to <italic>Cre</italic>-negative littermates, the number of empty lacunae was increased in the femoral heads in <italic>β-catenin<sup>Col2ER</sup></italic>mice (<xref rid="fig5" ref-type="fig">Figure 5E</xref>), but no changed in <italic>β-catenin<sup>OsxER</sup></italic>mice (<xref rid="fig6" ref-type="fig">Figure 6E</xref>). TUNEL staining revealed more apoptotic osteocytes in <italic>β-catenin<sup>Col2ER</sup></italic> mice compared to <italic>Cre</italic>-negative littermates (<xref rid="fig5" ref-type="fig">Figure 5F</xref>). All these findings indicate that loss-of-function of β-catenin in Col2<sup>+</sup> cells, but not in Osx<sup>+</sup> cells, led to an GONFH-like phenotype in femoral head. Furthermore, decreased Runx2, ALP and increased PPAR-γ, CEBP/α expressions in <italic>β-catenin<sup>Col2ER</sup></italic> mice (<xref rid="fig5" ref-type="fig">Figure 5G</xref>) revealed that this GONFH-like phenotype was caused by imbalance of osteogenic/adipogenic differentiation of Col2<sup>+</sup> cells.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><p>Deletion of <italic>β-catenin</italic> in Col2<sup>+</sup> cells leads to a GONFH-like phenotype. Femoral heads were harvested from 3-month-old <italic>β-catenin<sup>Col2ER</sup></italic>mice and <italic>Cre-</italic>negative littermates with 5 continuous dosage of TM injections (1 mg/10 g body weight) at the age of 2 weeks. (A) Gross anatomy analysis of femoral heads in <italic>β-catenin<sup>Col2ER</sup></italic>mice and <italic>Cre-</italic>negative littermates. (B) Representative μCT images and quantitative analysis of BV/TV, Tb. N, Tb. Th and Tb. Sp in the femoral heads of <italic>β-catenin<sup>Col2ER</sup></italic> mice. (C) ABH staining of femoral heads in <italic>β-catenin<sup>Col2ER</sup></italic> mice. a-d: high magnification images of representative subchondral bone region; Black triangle arrowheads: fat droplets; Black arrows: empty lacunae of osteocytes. (D) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in the femoral heads of <italic>β-catenin<sup>Col2ER</sup></italic> mice. (E) Histomorphological quantitative analysis of empty lacunae rate in the femoral heads of <italic>β-catenin<sup>Col2ER</sup></italic>mice. (F) TUNEL staining of osteocytes in the femoral heads of <italic>β-catenin<sup>Col2ER</sup></italic> mice. (G) IHC staining and quantitative analysis of Runx2, ALP, PPAR-γ and CEBP/α in the femoral heads of <italic>β-catenin<sup>Col2ER</sup></italic> mice.</p></caption>
<graphic xlink:href="560853v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><p>Loss-of-function of <italic>β-catenin</italic> in Osx<sup>+</sup> cells causes bone loss in the femoral heads. Femoral heads were harvested from 3-month-old <italic>β-catenin<sup>OsxER</sup></italic> mice and <italic>Cre-</italic>negative littermates with 5 continuous dosage of TM injections (1 mg/10 g body weight) at the age of 2 weeks. (A) Gross anatomy analysis of femoral heads in <italic>β-catenin<sup>OsxER</sup></italic> mice and <italic>Cre-</italic>negative littermates. (B) μCT images and quantitative analysis of BV/TV, Tb. N, Tb. Th and Tb. Sp in the femoral heads of <italic>β-catenin<sup>OsxER</sup></italic> mice. (C) ABH staining of femoral heads in <italic>β-catenin<sup>OsxER</sup></italic>mice. (D) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in the femoral heads of <italic>β-catenin<sup>OsxER</sup></italic>mice. (E) Histomorphological quantitative analysis of empty lacunae rate in the femoral heads of <italic>β-catenin<sup>OsxER</sup></italic>mice.</p></caption>
<graphic xlink:href="560853v2_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>Older <italic>β-catenin<sup>Col2ER</sup></italic>mice display subchondral bone destruction and collapse tendency in the femoral heads</title>
<p>Femoral head collapse occurs at the end-stage of GONFH and represents a poor joint function<sup>[<xref ref-type="bibr" rid="c41">41</xref>]</sup>. To determine the occurrence of femoral head collapse, we further analyzed 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice. Gross appearance showed that older <italic>β-catenin<sup>Col2ER</sup></italic> mice lost smooth and regular outline on the femoral heads compared to <italic>Cre</italic>-negative littermates and 3-month-old <italic>β-catenin<sup>Col2ER</sup></italic>mice (<xref rid="fig7" ref-type="fig">Figure 7A</xref>). μCT images showed severe bone loss (<xref rid="fig7" ref-type="fig">Figure 7B</xref>, <xref rid="fig7" ref-type="fig">7C</xref>), subchondral bone destruction (<xref rid="fig7" ref-type="fig">Figure 7B</xref>, yellow arrows), local collapse (<xref rid="fig7" ref-type="fig">Figure 7B</xref>, red arrows) and integral deformity (<xref rid="fig7" ref-type="fig">Figure 7B</xref>, red dotted lines) in the femoral heads of older <italic>β-catenin<sup>Col2ER</sup></italic> mice. μCT quantitative analysis confirmed a significant increase of subchondral bone defect area on the femoral head surface in older <italic>β-catenin<sup>Col2ER</sup></italic>mice (<xref rid="fig7" ref-type="fig">Figure 7D</xref>). Besides of these early necrotic changes including sparse bone trabeculae, accumulated fat droplets (<xref rid="fig7" ref-type="fig">Figure 7E</xref>, black triangles) and increased empty lacunae of osteoctyes (<xref rid="fig7" ref-type="fig">Figure 7E</xref>, black arrows, <xref rid="fig7" ref-type="fig">Figure 7F</xref>), ABH staining also showed subchondral bone destruction (<xref rid="fig7" ref-type="fig">Figure 7E</xref>, yellow arrows), femoral head collapse or deformity (<xref rid="fig7" ref-type="fig">Figure 7E</xref>, red arrows and red dotted lines) in older <italic>β-catenin<sup>Col2ER</sup></italic>mice. Compared to <italic>Cre</italic>-negative littermates, the older <italic>β-catenin<sup>Col2ER</sup></italic> mice presented a decrease of loading-bearing stiffness, indicating a poor biomechanical support of the femoral heads (<xref rid="fig7" ref-type="fig">Figure 7G</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><p>Older <italic>β-catenin<sup>Col2ER</sup></italic> mice display subchondral bone destruction and collapse tendency in femoral heads. Femoral heads were harvested from 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>Cre-</italic>negative littermates with 5 continuous dosage of TM injections (1 mg/10 g body weight) at the age of 2 weeks. (A) Gross anatomy analysis of femoral heads in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic>mice. (B) Representative μCT images of femoral heads in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic>mice. Red dotted lines: integral deformity. Red arrows: local collapse. Yellow arrows: subchondral bone destruction. (C) Quantitative analysis of BV/TV in the femoral heads in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic>mice. (D) Quantitative analysis of subchondral bone defect area on the femoral head surface in older <italic>β-catenin<sup>Col2ER</sup></italic> mice. (E) ABH staining of femoral heads in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice. a-c: high magnification images of representative subchondral bone region. Red dotted lines: integral deformity. Red arrows: local collapse. Black arrows: empty lacunae of osteoctyes. Black triangles: fat droplets. (F) Histomorphological quantitative analysis of empty lacunae rate. (G) Loading-bearing stiffness of the femoral heads in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic>mice.</p></caption>
<graphic xlink:href="560853v2_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2f">
<title>Wnt agonist 1 could not alleviate GONFH-like phenotype in <italic>β-catenin<sup>Col2ER</sup></italic>mice</title>
<p>As the therapeutic effects of Wnt agonist 1 on rat GONFH, we further determined whether it could alleviate the GONFH-like phenotype in <italic>β-catenin<sup>Col2ER</sup></italic> mice. After induction with TM, <italic>β-catenin<sup>Col2ER</sup></italic>mice were immediately injected with Wnt agonist 1 three times once week until they were analyzed at the age of 3 months. However, μCT images and quantitative analysis of BV/TV, Tb.N, Tb.Th and Tb.Sp showed severe bone loss were not restored in <italic>β-catenin<sup>Col2ER</sup></italic> mice by treating with Wnt agonist 1 (<xref rid="fig8" ref-type="fig">Figure 8A</xref>, <xref rid="fig8" ref-type="fig">8B</xref>). Accumulated fat droplets, sparse trabeculae and empty lacunae were still existed in the femoral heads of Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic> mice (<xref rid="fig8" ref-type="fig">Figure 8C</xref>-<xref rid="fig8" ref-type="fig">8E</xref>). IHC staining showed no change of decreased ALP and increased FABP4 in the femoral heads of <italic>β-catenin<sup>Col2ER</sup></italic>mice after Wnt agonist 1 treatment (<xref rid="fig8" ref-type="fig">Figure 8F</xref>, <xref rid="fig8" ref-type="fig">8G</xref>). These findings indicate that Wnt agonist 1 could not restore the imbalanced osteogenic/adipogenic differentiation of Col2<sup>+</sup> cells in <italic>β-catenin<sup>Col2ER</sup></italic>mice.</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><p>Systemic injection of Wnt agonist 1 can not alleviate the GONFH-like phenotype in <italic>β-catenin<sup>Col2ER</sup></italic> mice. <italic>β-catenin<sup>Col2ER</sup></italic> mice with 5 continuous dosage of TM injections (1 mg/10 g body weight) were treated with Wnt agonist 1 three times once week until sacrifice at the age of 3 months. (A) Representative μCT images of femoral heads in Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic> mice. (B) Quantitative analysis of BV/TV, Tb.N, Tb.Th and Tb.Sp in the femoral heads of Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic>mice. (C) ABH staining of the femoral heads in Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic> mice. a-b: high magnification images of subchondral bone region. Black triangles: fat droplets. (D) Histomorphological quantitative analysis of trabecular bone area and fat droplet area in the femoral heads of Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic> mice. (E) Histomorphological quantitative analysis of empty lacunae rate in the femoral heads of Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic>mice. (F, G) IHC staining and quantitative analysis of ALP and FABP4 in the femoral heads of Wnt agonist 1 treated <italic>β-catenin<sup>Col2ER</sup></italic>mice.</p></caption>
<graphic xlink:href="560853v2_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Despite it is well known that glucocorticoids are the certain etiology of GONFH, its pathogenesis remains largely unknown. Current evidence including reduced osteogenic differentiation ability of BMSCs from GONFH patients and clinical therapeutical effects of BMSCs transplantation indicates that GONFH could be resulted from abnormal differentiation of BMSCs<sup>[<xref ref-type="bibr" rid="c18">18</xref>–<xref ref-type="bibr" rid="c21">21</xref>]</sup>. Glucocorticoid-induced animal models are commonly used for GONFH research, and several previous studies have revealed that direct BMSCs modifications with miRNA<sup>[<xref ref-type="bibr" rid="c42">42</xref>, <xref ref-type="bibr" rid="c43">43</xref>]</sup>, lncRNA<sup>[<xref ref-type="bibr" rid="c44">44</xref>, <xref ref-type="bibr" rid="c45">45</xref>]</sup> and circRNA<sup>[<xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c46">46</xref>]</sup> or microenvironment interventions by injecting platelet-rich plasma<sup>[<xref ref-type="bibr" rid="c47">47</xref>, <xref ref-type="bibr" rid="c48">48</xref>]</sup>, exosome<sup>[<xref ref-type="bibr" rid="c49">49</xref>, <xref ref-type="bibr" rid="c50">50</xref>]</sup> and growth factors<sup>[<xref ref-type="bibr" rid="c51">51</xref>, <xref ref-type="bibr" rid="c52">52</xref>]</sup> could promote osteogenic differentiation of BMSCs and exhibit anti-GONFH effects in animals. In the present studies, we found severe trabecular bone loss and massive fat droplets accumulation in the necrotic femoral heads of GONFH patients and glucocorticoid-induced GONFH rats, confirming increased adipogenesis and decreased osteogenesis in GONFH pathogenesis. Dex inhibited osteogenic differentiation of rat BMSCs and promoted their adipogenic differentiation, revealing that this abnormal osteogenesis and adipogenesis in GONFH rats were caused by the imbalance in osteogenic/adipogenic differentiation of BMSCs. As β-catenin plays an important role in BMSCs differentiation, we then analyzed its role in GONFH pathogenesis. The results showed a significant inhibition of β-catenin signaling in the necrotic femoral heads of GONFH patients and glucocorticoid-induced GONFH rats, while Wnt agonist 1 attenuated accumulated fat droplets and sparse trabeculae in GONFH rats by activation of β-catenin signaling. The subsequent cellular experiments revealed that β-catenin activation restored the imbalance of osteogenic/adipogenic differentiation of BMSCs caused by long-term exposure of Dex. Overall, these findings indicate that β-catenin inhibition-induced imbalanced osteogenic/adipogenic differentiation of BMSCs contributed to GONFH.</p>
<p>BMSCs are a group of heterogeneous cells, and their majorities are derived from skeletal progenitors<sup>[<xref ref-type="bibr" rid="c27">27</xref>]</sup>. It has reported that both Col2<sup>+</sup> progenitors and Osx<sup>+</sup> progenitors provide a large proportion of BMSCs<sup>[<xref ref-type="bibr" rid="c28">28</xref>]</sup>. Adult transgenic mice with conditional deletion of <italic>β-catenin</italic> in Col2<sup>+</sup> cells, but not Osx<sup>+</sup> cells, displayed a GONFH-like phenotype. Extensive trabecular bone were replaced by fat droplets in the femoral head (especially in the subchondral bone region) of <italic>β-catenin<sup>Col2ER</sup></italic> mice compared to <italic>β-catenin<sup>OsxER</sup></italic> mice. Cell fate mapping revealed a apparent difference in the distributions of Osx<sup>+</sup> cells and Col2<sup>+</sup> cells in the femoral head when mice induced at 2-week-old. Besides of the similar parts with Osx<sup>+</sup> cells (osteoblasts, osteocytes and stromal cells underneath growth plate), Col2<sup>+</sup> cells also largely expressed in the chondrocytes of articular cartilage, secondary ossification center and growth plate. Whether these Col2<sup>+</sup> chondrocytes in secondary ossification center and growth plate caused this GONFH-like phenotype, as it has been reported that the osteogenic commitment of these Col2<sup>+</sup> chondrocytes<sup>[<xref ref-type="bibr" rid="c53">53</xref>, <xref ref-type="bibr" rid="c54">54</xref>]</sup>. At the age of 3 month, Col2<sup>+</sup> chondrocytes in the secondary ossification center and growth plate were almost replaced by Col2<sup>+</sup> osteoblasts, osteocytes and stromal cells, while GONFH-like phenotype including fat droplets accumulation and sparse bone trabeculae could be still observed in 6-month-old β-catenin<sup>Col2ER</sup> mice, indicating that not only Col2<sup>+</sup> chondrocytes but all Col2<sup>+</sup> cells in different cellular morphology were involved in this GONFH-like phenotype. Nine months of lineage trace further revealed that Col2<sup>+</sup> cells had self-renew ability and could continuously produced osteoblasts. The decreased ALP, Runx2 and increased CEBP/α and PPAR-γ in <italic>β-catenin<sup>Col2ER</sup></italic> mice revealed that deletion of <italic>β-catenin</italic> shifted the commitment of Col2<sup>+</sup> cells from osteoblasts to adipocytes, which should be responsible for this GONFH-like phenotype.</p>
<p>Femoral head collapse is the key feature of late stage GONFH and is disastrous to hip joint<sup>[<xref ref-type="bibr" rid="c55">55</xref>]</sup>. Although it has been well recognized that poor mechanical supports caused structural collapse of necrotic femoral head<sup>[<xref ref-type="bibr" rid="c56">56</xref>]</sup>, its detailed pathogenesis is poorly understood due to lack of ideal animal models. Glucocorticoid-induced bipedal and quadrupedal animal models only exhibit the early necrotic changes of GONFH<sup>[<xref ref-type="bibr" rid="c57">57</xref>]</sup>, without structure collapse of femoral head in MPS-induced rats. Other models using chemical or physical approaches are all failed to mimic full-range osteonecrosis of GONFH in humans<sup>[<xref ref-type="bibr" rid="c58">58</xref>]</sup>. Importantly, we found that femoral head collapse occurred spontaneously in older <italic>β-catenin<sup>Col2ER</sup></italic> mice. Besides the early necrotic changes including trabecular bone loss, empty lacunae and fat droplets accumulation, extensive subchondral bone destruction were identified in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice. Previous studies have revealed that strong trabeculae and integrated subchondral bone are critical to maintain femoral head morphology<sup>[<xref ref-type="bibr" rid="c59">59</xref>, <xref ref-type="bibr" rid="c60">60</xref>]</sup>. A significant decrease of loading-bearing stiffness confirmed a poor biomechanical supports in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice. Therefore, it could be concluded that β-catenin inhibition-induced imbalanced osteogenic/adipogenic differentiation of Col2<sup>+</sup> cells caused a poor biomechanical supports (manifesting with sparse trabeculae and subchondral bone destruction), eventually leading to femoral head collapse in <italic>β-catenin<sup>Col2ER</sup></italic> mice.</p>
<p>Osteocytes are the bone cells with longest life, up to decades within their mineralized environment<sup>[<xref ref-type="bibr" rid="c61">61</xref>, <xref ref-type="bibr" rid="c62">62</xref>]</sup>. However, numerous empty lacunae of osteocyte were observed in the necrotic femoral head of GONFH patients and glucocorticoid-induced rats. Glucocorticoids are known to induce cell apoptosis<sup>[<xref ref-type="bibr" rid="c63">63</xref>]</sup>, and TUNEL staining confirmed increased osteocyte apoptosis in the human and rat necrotic femoral heads, leaving behinds these empty lacunae. The importance of β-catenin in the regulation of apoptosis is well established in skeletal system<sup>[<xref ref-type="bibr" rid="c64">64</xref>, <xref ref-type="bibr" rid="c65">65</xref>]</sup>. Consistently, the expression of β-catenin was significantly decreased in the human and rat necrotic femoral heads. Moreover, we found that genetic deletion of β-catenin in Col2<sup>+</sup> cells spontaneously caused osteocyte apoptosis in mice and activation of β-catenin by systematically injecting Wnt agonist 1 alleviated osteocyte apoptosis in glucocorticoid-induced rats, which indicate that β-catenin inhibition-induced osteocyte apoptosis contributed to empty lacunae of GONFH.</p>
<p>There are some limitations in the present study. Firstly, Wnt agonist 1 is a cell-permeating activator of Wnt signaling that induces transcriptional activity dependent on β-catenin<sup>[<xref ref-type="bibr" rid="c66">66</xref>, <xref ref-type="bibr" rid="c67">67</xref>]</sup>. Thus, Wnt agonist 1 alleviated rat GONFH by activating β-catenin signaling, but could not rescue GONFH-like phenotype in <italic>β-catenin<sup>Col2ER</sup></italic> mice. Nevertheless, it remains unclear how Wnt agonist 1 works to activate β-catenin signaling. Secondly, <italic>β-catenin<sup>OsxER</sup></italic> mice presented few lipid droplet and empty lacunae but a significant decrease of bone mass in the femoral heads. Previous studies revealed that specific knockout of <italic>β-catenin</italic> in Osx-expressing cells promote osteoclast formation and activity<sup>[<xref ref-type="bibr" rid="c68">68</xref>, <xref ref-type="bibr" rid="c69">69</xref>]</sup>, while its exact mechanism of bone mass loss still need to be verified. Thirdly, bone damage caused a poor mechanical support is the key to femoral head collapse. Although it is well known that an extensive subchondral bone destruction finally led to femoral head collapse in 6-month-old <italic>β-catenin<sup>Col2ER</sup></italic> mice, the detailed mechanism why this subchondral bone destruction occurs with age is still unclear.</p>
<p>In summary, our studies revealed that β-catenin inhibition induces the imbalance in osteogenic/adipogenic differentiation of BMSCs and plays a crucial role in GONFH pathogenesis. We also provided a <italic>Col2</italic>-specific <italic>β-catenin</italic> knockout mouse model, for the first time, which mimics full spectrum of osteonecrosis phenotype of GONFH.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Human specimen collection</title>
<p>Fifteen necrotic femoral head samples were collected from GONFH patients (ARCO grades III-IV) who received arthroplasty surgery. Ten non-necrotic femoral head samples were acquired from femoral neck fracture patients. All experiments with human specimens were approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (2018KL-005).</p>
</sec>
<sec id="s4b">
<title>Animals and interventions</title>
<p>Thirty 2-month-old male Sprague-Dawley (SD) rats were purchased from the Animal Laboratory Center of Zhejiang Chinese Medical University (Zhejiang, China, SCXK 2014-0004), and randomly divided into the sham group, the GONFH group and the treatment group (n = 10 per group). We adopted Zheng’s methods to establish a glucocorticoid-induced GONFH rat model<sup>[<xref ref-type="bibr" rid="c9">9</xref>]</sup>. Firstly, rats in the GONFH group and the treatment group received once injection of lipopolysaccharide (0.2 mg/kg body weight, Sigma, USA) by tail vein, followed by three continuous intraperitoneal injections of 100 mg/kg body methylprednisolone (MPS, Pfizer, USA). At the subsequent 6 weeks, MPS were intraperitoneally injected at the dosage of 40 mg/kg body weight three times every week. Rats in the treatment group were intravenously injected with Wnt agonist 1 (5 mg/kg body weight, Selleck, USA) at synchronous frequency with MPS.</p>
<p><italic>Col2-CreER<sup>T2</sup></italic> mice, <italic>β-catenin<sup>flox/flox</sup></italic> mice, <italic>Osterix-CreER<sup>T2</sup></italic>mice and <italic>Rosa26<sup>tdTomato</sup></italic> mice were obtained from Jackson Laboratory. To map cell fate of Col2<sup>+</sup> cells and Osx<sup>+</sup> cells in the femoral head, <italic>Col2-CreER<sup>T2</sup>;Rosa26<sup>tdTomato</sup></italic>(<italic>Tomato<sup>Col2ER</sup></italic>) mice and <italic>Osterix-CreER<sup>T2</sup>;Rosa26<sup>tdTomato</sup></italic> (<italic>Tomato<sup>OsxER</sup></italic>) mice induced by intraperitoneally injecting with tamoxifen (TM, 1 mg/10g body weight/day, diluted in corn oil) for 5 consecutive days at the age of 2 or 4 weeks, and traced as long as 9-month-old. To further investigate the role of β-catenin in GONFH pathogenesis, <italic>Col2-CreER<sup>T2</sup>;β-catenin<sup>flox/flox</sup></italic> (<italic>β-catenin<sup>Col2ER</sup></italic>) mice and <italic>Osterix-CreER<sup>T2</sup>;β-catenin<sup>flox/flox</sup></italic> (<italic>β-catenin<sup>OsxER</sup></italic>) mice were generated and induced with 5 continuous injection of TM. After induction, Wnt agonist 1 (5 mg/kg body weight) was intravenously injected into <italic>β-catenin<sup>Col2ER</sup></italic> mice three times every week until they were sacrificed at the age of 3 months. All animal experiments were approved by the Animal Ethics Committee of Zhejiang Chinese Medical University (No. 20190401-10).</p>
</sec>
<sec id="s4c">
<title>Stereomicroscopy observation and biomechanical testing</title>
<p>Femoral head tissues harvested from human patients, glucocorticoid-induced GONFH rats, <italic>β-catenin<sup>Col2ER</sup></italic> mice and <italic>β-catenin<sup>OsxER</sup></italic> mice were viewed under a stereomicroscope (Model C-DSD230, Nikon, Japan) to assess their appearance characteristics. The fresh femoral head tissues were placed on the test platform of a biomechanical testing machine (EnduraTec TestBenchTM system, Minnetonka, MN, USA). The axial compression load was applied at a speed of 0.5 mm/min until femoral head deformation. The loading-bearing stiffness of femoral head was calculated by testing software.</p>
</sec>
<sec id="s4d">
<title>μCT analysis</title>
<p>Femoral head samples were scanned with a micro-computed tomography (μCT, Skyscan 1176 Bruker μCT, Kontich, Belgium) at a resolution of 9 μm. Three-dimensional (3D) structure was reconstructed using NRecon Software v1.6 as described previously<sup>[<xref ref-type="bibr" rid="c70">70</xref>]</sup>. The region of interest in the subchondral bone was selected for morphometric analysis including bone volume fraction (BV/TV, %), average trabecular thickness (Tb.Th, mm), average trabecular number (Tb.N, 1/mm), average trabecular separation (Tb.Sp, mm) and subchondral bone defect area (%).</p>
</sec>
<sec id="s4e">
<title>Histology, immunohistochemistry and histomorphometry</title>
<p>Femoral head tissues were processed into 3-μm-thick paraffin section or 10-μm-thick frozen section as described previously<sup>[<xref ref-type="bibr" rid="c71">71</xref>]</sup>. After deparaffinage and rehydration, sections were stained with Alcian Blue Hematoxylin for 1 hour and then Orange G for 1 min for histological analysis. After Alcian Blue Hematoxylin (ABH) / Orange G staining, bone tissue presented yellow color and cartilage was blue. The trabecular bone area (%), fat droplet area (%) and empty lacuna rate (%) were measured using OsteoMetrics software (Decatur, GA). The frozen sections were performed with 4’,6-diamidino-2-phenylindole (DAPI) staining and hematoxylin and eosin (H&amp;E) staining for evaluating <italic>Cre</italic>-recombination efficiency.</p>
<p>Immunohistochemistry (IHC) assay were performed on the paraffin sections according to the previously established procedures<sup>[<xref ref-type="bibr" rid="c72">72</xref>]</sup>. Briefly, sections were immersed into 0.01 M citrate buffer (Solarbio, Beijing, China) at 60L for 4 h to repair antigen. After washing with phosphate buffer (PBS) three times, the sections were incubated with primary antibodies including β-catenin (diluted 1:500, abcam, ab32572, UK), Runx2 (diluted 1:200, Abcam, ab76956, UK), alkaline phosphatase (ALP, diluted 1:200, ARIGO, ARG57422, CN), osteocalcin (OCN; diluted 1:200, Takara, UK), PPAR-γ (diluted 1:300, Abcam,ab19481, UK), CEBP/α (diluted 1:400, Huabio, EM1710-20, CA) and fatty acid-binding protein (FABP4, diluted 1:200, abcam, ab92501, UK) overnight at 4□. After incubation with secondary antibodies for 30 min at room temperature, tissue sections were stained with diaminobenzidine (DAB) solution to detect positive staining and hematoxylin for counterstaining. Mean density (IOD/Area) as the parameter of immunohistochemical quantitative analysis was evaluated using Image-Pro Plus software (Media Cybernetics, Silver Spring, USA).</p>
</sec>
<sec id="s4f">
<title>Rat BMSCs isolation and identification</title>
<p>BMSCs isolation were conducted as previously described<sup>[<xref ref-type="bibr" rid="c25">25</xref>]</sup>. Briefly, bone marrow cells were isolated from the proximal femur of 4-week-old SD rats. After centrifugation at 200 g for 10 min, cells were resuspended with α-MEM (Gibco, Grand Island, NY) containing 10% fetal bovine serum (FBS, Gibco, Grand Island, NY). By changing the medium 48 h later, no-adherent cells were removed and the primary BMSCs were harvested. At 100% confluence, primary cultures were detached using trypsin and subcultured at 8 × 10<sup>3</sup> cells/cm<sup>2</sup>. A total of 50 μL third passage (P3) BMSCs suspension (4 × 10<sup>6</sup>/mL) were mixed with 5 μL of rat CD90-APC, rat anti-CD29-BV421, rat anti-CD45-FITC or rat CD11b-PE (BD Pharmingen, Franklin Lakes, NJ, USA) in each flow cytometry tube. After incubation at room temperature for 30 min followed by twice washes of a staining buffer, the cells were resuspend with 500 μL staining buffer for flow cytometry analysis.</p>
</sec>
<sec id="s4g">
<title>Rat BMSCs intervention and staining</title>
<p>To investigate the role of glucocorticoids on BMSCs differentiation, P3 BMSCs were treated with gradient concentrations of dexamethasone (Dex, 0, 10, 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup>, 10<sup>5</sup> nM) (Selleck, Shanghai, China) with or without SKL2001 (a agonist of β-catenin) (Selleck, Shanghai, China) for 72 h. For oil-red O staining, BMSCs were treated with adipogenic medium (α-MEM containing 10% FBS, 0.25 mM methylisobutylxanthine, 5 μg/mL insulin, and 50 μM indomethacin) for 72 h followed by 5 μg/mL insulin alone for an additional 48 h. After fixed in 4% paraformaldehyde for 10 min, BMSCs were stained in 60% saturated oil-red O solution for 5 min. For ALP staining, BMSCs were treated with osteogenic medium (α-MEM containing 10% FBS, 50 μg/mL ascorbic acid and 5 mM β-glycerophosphate) for 14 d, fixed in 4% paraformaldehyde for 10 min and stained with ALP staining kit (Thermo Fisher Scientific, Rockford, IL, USA) for 15 min.</p>
</sec>
<sec id="s4h">
<title>Western blot analysis</title>
<p>According to the appearance and CT images, two piece (about 2*2*2 cm<sup>3</sup>) of necrotic tissues were cut from each human necrotic femoral head, and the corresponding region from human fractured femoral head. These necrotic and non-necrotic tissues were mixed and ground into powder after processed by liquid nitrogen, respectively. Tissue powder and rat P3 BMSCs were lysed by protein extraction reagent, and the liquid supernatant containing total protein was obtained through centrifuging at 12000 g for 20 min. Then, proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were incubated overnight with primary antibodies including β-catenin, Runx2, Osterix, ALP, PPAR-γ and CEBP/α at 1:1000 dilution. Next, the membranes were incubated with appropriate horseradish peroxidase-conjugated secondary antibodies at 37 ℃ for 1 h. The immune complexes were detected using a chemiluminescence kit and visualized via the ChemiDoc XRS Gel documentation system (Bio-rad, CA). The gray intensity was measured by the software of Quantity One (Bio-Rad, CA).</p>
</sec>
<sec id="s4i">
<title>Statistical analysis</title>
<p>All data were presented as mean ± standard deviation (SD). Statistical analyses including unpaired Student’s <italic>t</italic>-test (two groups) and one-way ANOVA followed by Tukey’s test (multiple groups) were performed with the software of SPSS 22.0 software. *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01 was considered statistically significant.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>Raw data are mainly attached in the current study. Any other data involving this study are available from the corresponding author upon request.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This work has been supported by Chinese National Natural Science Foundation (grants nos. 82074469, 82104885), Natural Science Foundation of Zhejiang Province (grants nos. LQ22H270001, LY21H270008, LR23H270001), Ningbo medical key discipline (grant no. 2022-B01), Ningbo Top Medical and Health Program (grant no. 2022020102).</p>
</ack>
<sec id="s6">
<title>Author Contributions</title>
<p>Di Chen, Chenjie Xia and Hongting Jin conceived this study. Chenjie Xia wrote the paper. Di Chen and Hongting Jin revised the paper. Chenjie Xia, Huihui Xu, Ping-er Wang, Liang Fang, Jiali Chen, Wenhua Yuan, Danqing Fu, Xucheng Wang performed the experiments and analyzed the data. Bangjian He, Luwei Xiao, Peijian Tong and Chengliang Wu collected the human samples.</p>
</sec>
<sec id="s7">
<title>Declaration of Interests</title>
<p>Competing interests: The authors declare no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>[1]</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>H</given-names></string-name>, <string-name><surname>Xue</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head</article-title>. <source>Clin Transl Med</source>. <year>2021</year>. <volume>11</volume>(<issue>6</issue>): <fpage>e447</fpage>.</mixed-citation></ref>
<ref id="c2"><label>[2]</label><mixed-citation publication-type="journal"><string-name><surname>Zaidi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>L</given-names></string-name>, <string-name><surname>Robinson</surname> <given-names>LJ</given-names></string-name>, <etal>et al.</etal> <article-title>ACTH protects against glucocorticoid-induced osteonecrosis of bone</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>. <volume>107</volume>(<issue>19</issue>): <fpage>8782</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c3"><label>[3]</label><mixed-citation publication-type="journal"><string-name><surname>Tao</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>T</given-names></string-name>, <string-name><surname>Rui</surname> <given-names>BY</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>ZZ</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>CQ</given-names></string-name>. <article-title>Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway</article-title>. <source>Theranostics</source>. <year>2017</year>. <volume>7</volume>(<issue>3</issue>): <fpage>733</fpage>–<lpage>750</lpage>.</mixed-citation></ref>
<ref id="c4"><label>[4]</label><mixed-citation publication-type="journal"><string-name><surname>Petek</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hannouche</surname> <given-names>D</given-names></string-name>, <string-name><surname>Suva</surname> <given-names>D</given-names></string-name>. <article-title>Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment</article-title>. <source>EFORT Open Rev</source> <year>2019</year>; <volume>4</volume>:<fpage>85</fpage>–<lpage>97</lpage>.</mixed-citation></ref>
<ref id="c5"><label>[5]</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)</article-title>. <source>J Orthop Translat</source>. <year>2020</year>. <volume>21</volume>: <fpage>100</fpage>–<lpage>110</lpage>.</mixed-citation></ref>
<ref id="c6"><label>[6]</label><mixed-citation publication-type="journal"><string-name><surname>Scaglione</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fabbri</surname> <given-names>L</given-names></string-name>, <string-name><surname>Celli</surname> <given-names>F</given-names></string-name>, <string-name><surname>Casella</surname> <given-names>F</given-names></string-name>, <string-name><surname>Guido</surname> <given-names>G</given-names></string-name>. <article-title>Hip replacement in femoral head osteonecrosis: current concepts</article-title>. <source>Clin Cases Miner Bone Metab</source> <year>2015</year>; <volume>12</volume>:<fpage>51</fpage>–<lpage>54</lpage>.</mixed-citation></ref>
<ref id="c7"><label>[7]</label><mixed-citation publication-type="journal"><string-name><surname>Qin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Yao</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits</article-title>. <source>Biomaterials</source>. <year>2015</year>. <volume>59</volume>: <fpage>125</fpage>–<lpage>43</lpage>.</mixed-citation></ref>
<ref id="c8"><label>[8]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Meng</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>Analysis of early stage osteonecrosis of the human femoral head and the mechanism of femoral head collapse</article-title>. <source>Int J Biol Sci</source>. <year>2018</year>. <volume>14</volume>(<issue>2</issue>): <fpage>156</fpage>–<lpage>164</lpage>.</mixed-citation></ref>
<ref id="c9"><label>[9]</label><mixed-citation publication-type="journal"><string-name><surname>Zheng</surname> <given-names>LZ</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Kong</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Steroid-associated osteonecrosis animal model in rats</article-title>. <source>J Orthop Translat</source>. <year>2018</year>. <volume>13</volume>: <fpage>13</fpage>–<lpage>24</lpage>.</mixed-citation></ref>
<ref id="c10"><label>[10]</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal> <article-title>Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply</article-title>. <source>Cell Death Dis</source>. <year>2021</year>. <volume>12</volume>(<issue>11</issue>): <fpage>1035</fpage>.</mixed-citation></ref>
<ref id="c11"><label>[11]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ren</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>. <article-title>The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature</article-title>. <source>Gene</source>. <year>2018</year>. <volume>671</volume>: <fpage>103</fpage>–<lpage>109</lpage>.</mixed-citation></ref>
<ref id="c12"><label>[12]</label><mixed-citation publication-type="journal"><string-name><surname>Lavernia</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Sierra</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Grieco</surname> <given-names>FR</given-names></string-name>. <article-title>Osteonecrosis of the femoral head</article-title>. <source>J Am Acad Orthop Surg</source>. <year>1999</year>. <volume>7</volume>(<issue>4</issue>): <fpage>250</fpage>–<lpage>61</lpage>.</mixed-citation></ref>
<ref id="c13"><label>[13]</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Greenspan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gershwin</surname> <given-names>ME</given-names></string-name>. <article-title>Osteonecrosis: current perspectives on pathogenesis and treatment</article-title>. <source>Semin Arthritis Rheum</source>. <year>1993</year>. <volume>23</volume>(<issue>1</issue>): <fpage>47</fpage>–<lpage>69</lpage>.</mixed-citation></ref>
<ref id="c14"><label>[14]</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>CY</given-names></string-name>, <string-name><surname>Rao</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Yue</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis</article-title>. <source>Sci Adv</source>. <year>2022</year>. <volume>8</volume>(<issue>15</issue>): <fpage>eabg8335</fpage>.</mixed-citation></ref>
<ref id="c15"><label>[15]</label><mixed-citation publication-type="journal"><string-name><surname>Zalavras</surname> <given-names>C</given-names></string-name>, <string-name><surname>Shah</surname> <given-names>S</given-names></string-name>, <string-name><surname>Birnbaum</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Frenkel</surname> <given-names>B</given-names></string-name>. <article-title>Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis</article-title>. <source>Crit Rev Eukaryot Gene Expr</source>. <year>2003</year>. <volume>13</volume>(<issue>2-4</issue>): <fpage>221</fpage>–<lpage>35</lpage>.</mixed-citation></ref>
<ref id="c16"><label>[16]</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Roh</surname> <given-names>HL</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>CH</given-names></string-name>, <string-name><surname>Jung</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Suh</surname> <given-names>KT</given-names></string-name>. <article-title>Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor</article-title>. <source>J Orthop Res</source>. <year>2006</year>. <volume>24</volume>(<issue>4</issue>): <fpage>604</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c17"><label>[17]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>W</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>ZC</given-names></string-name>, <etal>et al.</etal> <article-title>Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head</article-title>. <source>Orthopedics</source>. <year>2008</year>. <volume>31</volume>(<issue>5</issue>): <fpage>444</fpage>.</mixed-citation></ref>
<ref id="c18"><label>[18]</label><mixed-citation publication-type="journal"><string-name><surname>Houdek</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Wyles</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Packard</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Terzic</surname> <given-names>A</given-names></string-name>, <string-name><surname>Behfar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sierra</surname> <given-names>RJ</given-names></string-name>. <article-title>Decreased Osteogenic Activity of Mesenchymal Stem Cells in Patients With Corticosteroid-Induced Osteonecrosis of the Femoral Head</article-title>. <source>J Arthroplasty</source>. <year>2016</year>. <volume>31</volume>(<issue>4</issue>): <fpage>893</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c19"><label>[19]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>QM</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>FQ</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>QL</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>LG</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>WJ</given-names></string-name>. <article-title>Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis</article-title>. <source>Int J Surg</source>. <year>2019</year>. <volume>69</volume>: <fpage>23</fpage>–<lpage>31</lpage>.</mixed-citation></ref>
<ref id="c20"><label>[20]</label><mixed-citation publication-type="journal"><string-name><surname>Tabatabaee</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Saberi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Parvizi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mortazavi</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Farzan</surname> <given-names>M</given-names></string-name>. <article-title>Combining Concentrated Autologous Bone Marrow Stem Cells Injection With Core Decompression Improves Outcome for Patients with Early-Stage Osteonecrosis of the Femoral Head: A Comparative Study</article-title>. <source>J Arthroplasty</source>. <year>2015</year>. <volume>30</volume>(<issue>9 Suppl</issue>): <fpage>11</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c21"><label>[21]</label><mixed-citation publication-type="journal"><string-name><surname>Gangji</surname> <given-names>V</given-names></string-name>, <string-name><surname>Hauzeur</surname> <given-names>JP</given-names></string-name>. <article-title>Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique</article-title>. <source>J Bone Joint Surg Am</source>. <year>2005</year>. <volume>87 Suppl 1</volume>(<issue>Pt 1</issue>): <fpage>106</fpage>–<lpage>12</lpage>.</mixed-citation></ref>
<ref id="c22"><label>[22]</label><mixed-citation publication-type="journal"><string-name><surname>Yin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>YB</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>YS</given-names></string-name>. <article-title>Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis</article-title>. <source>Chin Med J (Engl</source>). <year>2006</year>. <volume>119</volume>(<issue>7</issue>): <fpage>581</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c23"><label>[23]</label><mixed-citation publication-type="journal"><string-name><surname>Han</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gong</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>G</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>W</given-names></string-name>. <article-title>The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor</article-title>. <source>Stem Cell Res Ther</source>. <year>2019</year>. <volume>10</volume>(<issue>1</issue>): <fpage>377</fpage>.</mixed-citation></ref>
<ref id="c24"><label>[24]</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>G</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Z</given-names></string-name>, <etal>et al.</etal> <article-title>Circular RNA CDR1as promotes adipogenic and suppresses osteogenic differentiation of BMSCs in steroid-induced osteonecrosis of the femoral head</article-title>. <source>Bone</source>. <year>2020</year>. <volume>133</volume>: <fpage>115258</fpage>.</mixed-citation></ref>
<ref id="c25"><label>[25]</label><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> <article-title>CD41-deficient exosomes from non-traumatic femoral head necrosis tissues impair osteogenic differentiation and migration of mesenchymal stem cells</article-title>. <source>Cell Death Dis</source>. <year>2020</year>. <volume>11</volume>(<issue>4</issue>): <fpage>293</fpage>.</mixed-citation></ref>
<ref id="c26"><label>[26]</label><mixed-citation publication-type="journal"><string-name><surname>Feng</surname> <given-names>X</given-names></string-name>, <string-name><surname>Xiang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Jia</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>CircHGF suppressed cell proliferation and osteogenic differentiation of BMSCs in ONFH via inhibiting miR-25-3p binding to SMAD7</article-title>. <source>Mol Ther Nucleic Acids</source>. <year>2022</year>. <volume>28</volume>: <fpage>99</fpage>–<lpage>113</lpage>.</mixed-citation></ref>
<ref id="c27"><label>[27]</label><mixed-citation publication-type="journal"><string-name><surname>Gao</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Jing</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Su</surname> <given-names>J</given-names></string-name>. <article-title>Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>. <volume>9</volume>: <fpage>787118</fpage>.</mixed-citation></ref>
<ref id="c28"><label>[28]</label><mixed-citation publication-type="journal"><string-name><surname>Ono</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ono</surname> <given-names>W</given-names></string-name>, <string-name><surname>Nagasawa</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kronenberg</surname> <given-names>HM</given-names></string-name>. <article-title>A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones</article-title>. <source>Nat Cell Biol</source>. <year>2014</year>. <volume>16</volume>(<issue>12</issue>): <fpage>1157</fpage>–<lpage>67</lpage>.</mixed-citation></ref>
<ref id="c29"><label>[29]</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Strecker</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma</article-title>. <source>PLoS One</source>. <year>2013</year>. <volume>8</volume>(<issue>8</issue>): <fpage>e71318</fpage>.</mixed-citation></ref>
<ref id="c30"><label>[30]</label><mixed-citation publication-type="journal"><string-name><surname>Song</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ono</surname> <given-names>N</given-names></string-name>, <string-name><surname>Bringhurst</surname> <given-names>FR</given-names></string-name>, <string-name><surname>Kronenberg</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>J</given-names></string-name>. <article-title>Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes</article-title>. <source>J Bone Miner Res</source>. <year>2012</year>. <volume>27</volume>(<issue>11</issue>): <fpage>2344</fpage>–<lpage>58</lpage>.</mixed-citation></ref>
<ref id="c31"><label>[31]</label><mixed-citation publication-type="journal"><string-name><surname>Yuan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Luo</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells</article-title>. <source>Curr Stem Cell Res Ther</source>. <year>2016</year>. <volume>11</volume>(<issue>3</issue>): <fpage>216</fpage>–<lpage>25</lpage>.</mixed-citation></ref>
<ref id="c32"><label>[32]</label><mixed-citation publication-type="journal"><string-name><surname>Takada</surname> <given-names>I</given-names></string-name>, <string-name><surname>Kouzmenko</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Kato</surname> <given-names>S</given-names></string-name>. <article-title>Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis</article-title>. <source>Nat Rev Rheumatol</source>. <year>2009</year>. <volume>5</volume>(<issue>8</issue>): <fpage>442</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c33"><label>[33]</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation</article-title>. <source>Curr Stem Cell Res Ther</source>. <year>2016</year>. <volume>11</volume>(<issue>3</issue>): <fpage>247</fpage>–<lpage>54</lpage>.</mixed-citation></ref>
<ref id="c34"><label>[34]</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Yougui pills exert osteoprotective effects on rabbit steroid-related osteonecrosis of the femoral head by activating β-catenin</article-title>. <source>Biomed Pharmacother</source>. <year>2019</year>. <volume>120</volume>: <fpage>109520</fpage>.</mixed-citation></ref>
<ref id="c35"><label>[35]</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname> <given-names>XY</given-names></string-name>, <string-name><surname>Li</surname> <given-names>HN</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head</article-title>. <source>Saudi Pharm J</source>. <year>2021</year>. <volume>29</volume>(<issue>12</issue>): <fpage>1405</fpage>–<lpage>1415</lpage>.</mixed-citation></ref>
<ref id="c36"><label>[36]</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>XJ</given-names></string-name>, <string-name><surname>Shen</surname> <given-names>YS</given-names></string-name>, <string-name><surname>He</surname> <given-names>MC</given-names></string-name>, <etal>et al.</etal> <article-title>Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway</article-title>. <source>Biomed Pharmacother</source>. <year>2019</year>. <volume>112</volume>: <fpage>108746</fpage>.</mixed-citation></ref>
<ref id="c37"><label>[37]</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yeersheng</surname> <given-names>R</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>W</given-names></string-name>. <article-title>Hypoxia Enhanced Bone Regeneration Through the HIF-1α /β-Catenin Pathway in Femoral Head Osteonecrosis</article-title>. <source>Am J Med Sci</source>. <year>2021</year>. <volume>362</volume>(<issue>1</issue>): <fpage>78</fpage>–<lpage>91</lpage>.</mixed-citation></ref>
<ref id="c38"><label>[38]</label><mixed-citation publication-type="journal"><string-name><surname>Yu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Fan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ge</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Dang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>K</given-names></string-name>. <article-title>Lithium prevents rat steroid-related osteonecrosis of the femoral head by β-catenin activation</article-title>. <source>Endocrine</source>. <year>2016</year>. <volume>52</volume>(<issue>2</issue>): <fpage>380</fpage>–<lpage>90</lpage>.</mixed-citation></ref>
<ref id="c39"><label>[39]</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>YL</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dang</surname> <given-names>XQ</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>KZ</given-names></string-name>. <article-title>Apoptosis associated with Wnt/β-catenin pathway leads to steroid-induced avascular necrosis of femoral head</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2015</year>. <volume>16</volume>: <fpage>132</fpage>.</mixed-citation></ref>
<ref id="c40"><label>[40]</label><mixed-citation publication-type="journal"><string-name><surname>Tencerova</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kassem</surname> <given-names>M</given-names></string-name>. <article-title>The Bone Marrow-Derived Stromal Cells: Commitment and Regulation of Adipogenesis</article-title>. <source>Front Endocrinol (Lausanne</source>). <year>2016</year>. <volume>7</volume>: <fpage>127</fpage>.</mixed-citation></ref>
<ref id="c41"><label>[41]</label><mixed-citation publication-type="journal"><string-name><surname>Hines</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Jo</surname> <given-names>WL</given-names></string-name>, <string-name><surname>Cui</surname> <given-names>Q</given-names></string-name>, <etal>et al.</etal> <article-title>Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment</article-title>. <source>J Korean Med Sci</source>. <year>2021</year>. <volume>36</volume>(<issue>24</issue>): <fpage>e177</fpage>.</mixed-citation></ref>
<ref id="c42"><label>[42]</label><mixed-citation publication-type="journal"><string-name><surname>Cao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>H</given-names></string-name>. <article-title>Reciprocal effect of microRNA-224 on osteogenesis and adipogenesis in steroid-induced osteonecrosis of the femoral head</article-title>. <source>Bone</source>. <year>2021</year>. <volume>145</volume>: <fpage>115844</fpage>.</mixed-citation></ref>
<ref id="c43"><label>[43]</label><mixed-citation publication-type="journal"><string-name><surname>Gu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1</article-title>. <source>Sci Rep</source>. <year>2016</year>. <volume>6</volume>: <fpage>38491</fpage>.</mixed-citation></ref>
<ref id="c44"><label>[44]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>LncRNA expression profiling of BMSCs in osteonecrosis of the femoral head associated with increased adipogenic and decreased osteogenic differentiation</article-title>. <source>Sci Rep</source>. <year>2018</year>. <volume>8</volume>(<issue>1</issue>): <fpage>9127</fpage>.</mixed-citation></ref>
<ref id="c45"><label>[45]</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>LINC00473-modified bone marrow mesenchymal stem cells incorporated thermosensitive PLGA hydrogel transplantation for steroid-induced osteonecrosis of femoral head: A detailed mechanistic study and validity evaluation</article-title>. <source>Bioeng Transl Med</source>. <year>2022</year>. <volume>7</volume>(<issue>2</issue>): <fpage>e10275</fpage>.</mixed-citation></ref>
<ref id="c46"><label>[46]</label><mixed-citation publication-type="journal"><string-name><surname>Xiang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Weng</surname> <given-names>X</given-names></string-name>. <article-title>Changed cellular functions and aberrantly expressed miRNAs and circRNAs in bone marrow stem cells in osteonecrosis of the femoral head</article-title>. <source>Int J Mol Med</source>. <year>2020</year>. <volume>45</volume>(<issue>3</issue>): <fpage>805</fpage>–<lpage>815</lpage>.</mixed-citation></ref>
<ref id="c47"><label>[47]</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Li</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Platelet-rich plasma promotes bone formation, restrains adipogenesis and accelerates vascularization to relieve steroids-induced osteonecrosis of the femoral head</article-title>. <source>Platelets</source>. <year>2021</year>. <volume>32</volume>(<issue>7</issue>): <fpage>950</fpage>–<lpage>959</lpage>.</mixed-citation></ref>
<ref id="c48"><label>[48]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Luan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>Z</given-names></string-name>, <etal>et al.</etal> <article-title>Therapeutic effect of platelet-rich plasma on glucocorticoid-induced rat bone marrow mesenchymal stem cells in vitro</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2022</year>. <volume>23</volume>(<issue>1</issue>): <fpage>151</fpage>.</mixed-citation></ref>
<ref id="c49"><label>[49]</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head</article-title>. <source>Stem Cell Res Ther</source>. <year>2020</year>. <volume>11</volume>(<issue>1</issue>): <fpage>480</fpage>.</mixed-citation></ref>
<ref id="c50"><label>[50]</label><mixed-citation publication-type="journal"><string-name><surname>Fang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>P</given-names></string-name>. <article-title>Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head</article-title>. <source>Drug Des Devel Ther</source>. <year>2019</year>. <volume>13</volume>: <fpage>45</fpage>–<lpage>55</lpage>.</mixed-citation></ref>
<ref id="c51"><label>[51]</label><mixed-citation publication-type="journal"><string-name><surname>Guzman</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Maruyama</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moeinzadeh</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits</article-title>. <source>Stem Cell Res Ther</source>. <year>2021</year>. <volume>12</volume>(<issue>1</issue>): <fpage>503</fpage>.</mixed-citation></ref>
<ref id="c52"><label>[52]</label><mixed-citation publication-type="journal"><string-name><surname>Rackwitz</surname> <given-names>L</given-names></string-name>, <string-name><surname>Eden</surname> <given-names>L</given-names></string-name>, <string-name><surname>Reppenhagen</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>Stem cell-mand growth factor-based regenerative therapies for avascular necrosis of the femoral head</article-title>. <source>Stem Cell Res Ther</source>. <year>2012</year>. <volume>3</volume>(<issue>1</issue>): <fpage>7</fpage>.</mixed-citation></ref>
<ref id="c53"><label>[53]</label><mixed-citation publication-type="journal"><string-name><surname>Shu</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>YL</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>XT</given-names></string-name>, <etal>et al.</etal> <article-title>Tracing the skeletal progenitor transition during postnatal bone formation</article-title>. <source>Cell Stem Cell</source>. <year>2021</year>. <volume>28</volume>(<issue>12</issue>): <fpage>2122</fpage>–<lpage>2136</lpage>.e3.</mixed-citation></ref>
<ref id="c54"><label>[54]</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Type II collagen-positive progenitors are important stem cells in controlling skeletal development and vascular formation</article-title>. <source>Bone Res</source>. <year>2022</year>. <volume>10</volume>(<issue>1</issue>): <fpage>46</fpage>.</mixed-citation></ref>
<ref id="c55"><label>[55]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>W</given-names></string-name>, <string-name><surname>Ling</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>AAV-Anti-miR-214 Prevents Collapse of the Femoral Head in Osteonecrosis by Regulating Osteoblast and Osteoclast Activities</article-title>. <source>Mol Ther Nucleic Acids</source>. <year>2019</year>. <volume>18</volume>: <fpage>841</fpage>–<lpage>850</lpage>.</mixed-citation></ref>
<ref id="c56"><label>[56]</label><mixed-citation publication-type="journal"><string-name><surname>Fan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Peng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Qin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>S</given-names></string-name>. <article-title>Experimental animal models of osteonecrosis</article-title>. <source>Rheumatol Int</source>. <year>2011</year>. <volume>31</volume>(<issue>8</issue>): <fpage>983</fpage>–<lpage>94</lpage>.</mixed-citation></ref>
<ref id="c57"><label>[57]</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gong</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Deasey</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Cui</surname> <given-names>Q</given-names></string-name>. <article-title>Animal models of steroid-induced osteonecrosis of the femoral head-a comprehensive research review up to 2018</article-title>. <source>Int Orthop</source>. <year>2018</year>. <volume>42</volume>(<issue>7</issue>): <fpage>1729</fpage>–<lpage>1737</lpage>.</mixed-citation></ref>
<ref id="c58"><label>[58]</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>An animal model of early-stage femoral head osteonecrosis induced by cryo-insult in small tailed Han sheep</article-title>. <source>J Orthop Translat</source>. <year>2021</year>. <volume>26</volume>: <fpage>84</fpage>–<lpage>91</lpage>.</mixed-citation></ref>
<ref id="c59"><label>[59]</label><mixed-citation publication-type="journal"><string-name><surname>Kawano</surname> <given-names>K</given-names></string-name>, <string-name><surname>Motomura</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ikemura</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>Differences in the microarchitectural features of the lateral collapsed lesion between osteonecrosis and subchondral insufficiency fracture of the femoral head</article-title>. <source>Bone</source>. <year>2020</year>. <volume>141</volume>: <fpage>115585</fpage>.</mixed-citation></ref>
<ref id="c60"><label>[60]</label><mixed-citation publication-type="journal"><string-name><surname>Motomura</surname> <given-names>G</given-names></string-name>, <string-name><surname>Yamamoto</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yamaguchi</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Morphological analysis of collapsed regions in osteonecrosis of the femoral head</article-title>. <source>J Bone Joint Surg Br</source>. <year>2011</year>. <volume>93</volume>(<issue>2</issue>): <fpage>184</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c61"><label>[61]</label><mixed-citation publication-type="journal"><string-name><surname>Dallas</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Prideaux</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bonewald</surname> <given-names>LF</given-names></string-name>. <article-title>The osteocyte: an endocrine cell … and more</article-title>. <source>Endocr Rev</source>. <year>2013</year>. <volume>34</volume>(<issue>5</issue>): <fpage>658</fpage>–<lpage>90</lpage>.</mixed-citation></ref>
<ref id="c62"><label>[62]</label><mixed-citation publication-type="journal"><string-name><surname>Bonewald</surname> <given-names>LF.</given-names></string-name> <article-title>The amazing osteocyte</article-title>. <source>J Bone Miner Res</source>. <year>2011</year>. <volume>26</volume>(<issue>2</issue>): <fpage>229</fpage>–<lpage>38</lpage>.</mixed-citation></ref>
<ref id="c63"><label>[63]</label><mixed-citation publication-type="journal"><string-name><surname>Weinstein</surname> <given-names>RS.</given-names></string-name> <article-title>Glucocorticoid-induced osteonecrosis</article-title>. <source>Endocrine</source>. <year>2012</year>. <volume>41</volume>(<issue>2</issue>): <fpage>183</fpage>–<lpage>90</lpage>.</mixed-citation></ref>
<ref id="c64"><label>[64]</label><mixed-citation publication-type="journal"><string-name><surname>Jähn</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lara-Castillo</surname> <given-names>N</given-names></string-name>, <string-name><surname>Brotto</surname> <given-names>L</given-names></string-name>, <string-name><surname>Mo</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Brotto</surname> <given-names>M</given-names></string-name> <etal>et al.</etal> <article-title>Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin</article-title>. <source>Eur Cell Mater</source> <year>2012</year>; <volume>24</volume>:<fpage>197</fpage>–<lpage>209</lpage>; discussion 209-210.</mixed-citation></ref>
<ref id="c65"><label>[65]</label><mixed-citation publication-type="journal"><string-name><surname>Kitase</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Barragan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Qing</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kondoh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>JX</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>ML</given-names></string-name> <etal>et al.</etal> <article-title>Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways</article-title>. <source>J Bone Miner Res</source> <year>2010</year>; <volume>25</volume>:<fpage>2657</fpage>–<lpage>2668</lpage>.</mixed-citation></ref>
<ref id="c66"><label>[66]</label><mixed-citation publication-type="journal"><string-name><surname>Lim</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Kania</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Wijesuriya</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title>Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells</article-title>. <source>J Neurochem</source>. <year>2008</year>. <volume>106</volume>(<issue>4</issue>): <fpage>1855</fpage>–<lpage>65</lpage>.</mixed-citation></ref>
<ref id="c67"><label>[67]</label><mixed-citation publication-type="journal"><string-name><surname>Kuncewitch</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>WL</given-names></string-name>, <string-name><surname>Corbo</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>WNT Agonist Decreases Tissue Damage and Improves Renal Function After Ischemia-Reperfusion</article-title>. <source>Shock</source>. <year>2015</year>. <volume>43</volume>(<issue>3</issue>): <fpage>268</fpage>–<lpage>75</lpage>.</mixed-citation></ref>
<ref id="c68"><label>[68]</label><mixed-citation publication-type="journal"><string-name><surname>Yu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Xuan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain</article-title>. <source>J Bone Miner Metab</source>. <year>2018</year>. <volume>36</volume>(<issue>5</issue>): <fpage>560</fpage>–<lpage>572</lpage>.</mixed-citation></ref>
<ref id="c69"><label>[69]</label><mixed-citation publication-type="journal"><string-name><surname>Song</surname> <given-names>L</given-names></string-name>, <string-name><surname>Li</surname> <given-names>H</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> <article-title>Postnatal deletion of β-catenin in preosteoblasts regulates global energy metabolism through increasing bone resorption and adipose tissue fibrosis</article-title>. <source>Bone</source>. <year>2022</year>. <volume>156</volume>: <fpage>116320</fpage>.</mixed-citation></ref>
<ref id="c70"><label>[70]</label><mixed-citation publication-type="journal"><string-name><surname>Xia</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Activation of β-catenin in Col2-expressing chondrocytes leads to osteoarthritis-like defects in hip joint</article-title>. <source>J Cell Physiol</source>. <year>2019</year>. <volume>234</volume>(<issue>10</issue>): <fpage>18535</fpage>–<lpage>18543</lpage>.</mixed-citation></ref>
<ref id="c71"><label>[71]</label><mixed-citation publication-type="journal"><string-name><surname>Xia</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ge</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>P</given-names></string-name> <etal>et al.</etal> <article-title>TGF-β/Smad2 signalling regulates enchondral bone formation of Gli1+ periosteal cells during fracture healing</article-title>. <source>Cell Prolif</source> <year>2020</year>; <volume>53</volume>:<fpage>e12904</fpage>.</mixed-citation></ref>
<ref id="c72"><label>[72]</label><mixed-citation publication-type="journal"><string-name><surname>Xia</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Fang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Bushenhuoxue formula promotes osteogenic differentiation of growth plate chondrocytes through β-catenin-dependent manner during osteoporosis</article-title>. <source>Biomed Pharmacother</source>. <year>2020</year>. <volume>127</volume>: <fpage>110170</fpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92469.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Yaoting</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Wuhan University</institution>
</institution-wrap>
<city>Wuhan</city>
<country>China</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study presents <bold>valuable</bold> findings on the mechanism of glucocorticoid-induced osteonecrosis of the femoral head. The data were collected and analyzed using <bold>solid</bold>, validated methodology and can be used as a starting point for functional studies of development of glucocorticoid-induced osteonecrosis. This paper would be of interest to cell biologists and biophysicists working on potential pharmacological treatments for glucocorticoid-induced osteonecrosis.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92469.2.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The manuscript by Xia et al. investigated the mechanisms underlying Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). The authors observed that abnormal osteogenesis and adipogenesis is associated with decreased β-catenin in the necrotic femoral head of GONFH patients and inhibition of β-catenin signaling leads to abnormal osteogenesis and adipogenesis in GONFH rats. Of interest, deletion of β-catenin in Col2-expressing cells rather than in osx-expressing cells leads to a GONFH-like phenotype in femoral head of mice.</p>
<p>Strengths:</p>
<p>A strength of the study is that it sets up a Col2-expressing cell-specific β-catenin knockout mouse model that mimics full spectrum of osteonecrosis phenotype of GONFH. This is interesting and provides new insights into the understanding of GONFH. Overall, the data are solid and support their conclusions.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92469.2.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this manuscript, the authors reported a study to uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). In this study, they first observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients, but the exact pathological mechanisms of GONFH remain unknown. They then performed in vivo and in vitro studies to further revealed that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation bone marrow stromal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats, and specific deletion of β-catenin in Col2+ cells shifted BMSCs commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice.</p>
<p>Strengths:</p>
<p>This innovative study provides strong evidence supporting that β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation that contributes to the development of GONFH. This study also identifies an ideal genetic modified mouse model of GONFH. Overall, the experiment is logically designed, the figures are clear, and the data generated from humans and animals is abundant supporting their conclusions.</p>
<p>Weaknesses:</p>
<p>Lack of the discussion to explain how the Wnt agonist 1 works. There are several types of Wnt ligands. It is not clear if this agonist only targets Wnt1 or other Wnts as well? Also, why Wnt agonist 1 couldn't rescue the GONFH-like phenotype in β-cateninCol2ER mice needs to be discussed.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92469.2.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this manuscript, the authors are trying to delineate the mechanism underlying the osteonecrosis of the femoral head.</p>
<p>Strengths:</p>
<p>The authors provided compelling in vivo and in vitro data to demonstrate Col2+ cells and Osx+ cells were differentially expressed in the</p>
<p>
the femoral head. Moreover, inducible knockout of β-catenin in Col2+ cells but not</p>
<p>
Osx+ cells lead to a GONFH-like phenotype including fat accumulation, subchondral</p>
<p>
bone destruction and femoral head collapse, indicating that imbalance of osteogenic/adipogenic differentiation of Col2+ cells play an important role in GONFH pathogenesis. Therefore, this manuscript provided the mechanistic insights of osteonecrosis as well as potential therapeutic target for disease treatment.</p>
<p>Weaknesses: Additional in depth discussion regarding the phenotype observed in mice is highly encouraged.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92469.2.sa4</article-id>
<title-group>
<article-title>Author Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xia</surname>
<given-names>Chenjie</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5987-4146</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Huihui</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fang</surname>
<given-names>Liang</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jiali</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Wenhua</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Danqing</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xucheng</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Bangjian</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Luwei</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Chengliang</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tong</surname>
<given-names>Peijian</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Di</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4258-3457</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Pinger</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Hongting</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8795-0874</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>Summary:</p>
<p>The manuscript by Xia et al. investigated the mechanisms underlying Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). The authors observed that abnormal osteogenesis and adipogenesis are associated with decreased β-catenin in the necrotic femoral head of GONFH patients, and that the inhibition of β-catenin signalling leads to abnormal osteogenesis and adipogenesis in GONFH rats. Of interest, the deletion of β-catenin in Col2-expressing cells rather than in Osx-expressing cells leads to a GONFH-like phenotype in the femoral head of mice.</p>
<p>Strengths:</p>
<p>A strength of the study is that it sets up a Col2-expressing cell-specific β-catenin knockout mouse model that mimics the full spectrum of osteonecrosis phenotype of GONFH. This is interesting and provides new insights into the understanding of GONFH. Overall, the data are solid and support their conclusions.</p>
<p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p>
<p>1. Fig. 1I should be quantified and presented as bar graphs to make it consistent with other data, and the significance should be shown.</p>
</disp-quote>
<p>Reply: Thanks for your comments. We have provided the quantitative bar graph in the new version.</p>
<disp-quote content-type="editor-comment">
<p>1. Fig. 2H, beta-catenin, ALP and FABP4 should be labled below the X axis. Moreover, the pattern of Fig. 2H is different from other bar graphs and the dots for individual samples are missing, so I could not judge the N values for the experiments. N values should also be provided for Fig. 3.</p>
</disp-quote>
<p>Reply: Thanks for your comments. We have added the labels of beta-catenin, ALP and FABP4 below the X axis in Fig. 2H. The modes of quantitative bar graphs were changed to show the N values in the each experiment.</p>
<disp-quote content-type="editor-comment">
<p>1. Fig. 4 shows the fate mapping of Col2+ cells and Osx+ cells in the femoral head. In this regard, the authors presented images for Col2-expressing cells at all the indicated time points, i.e. 1, 3, 6, and 9 months, but only presented images for Osx-expressing cells for 1 month while those for 3, 6, and 9 months are missing.</p>
</disp-quote>
<p>Reply: Thanks for your comments. Here, we showed that the expression of Osx+ cells in the femoral head were total different with Col2+ cells at the age of 3, 6 month, further indicating they were two different progenitor lineage cells.</p>
<fig id="sa4fig1">
<label>Author response image 1.</label>
<graphic mime-subtype="jpg" xlink:href="elife-92469-sa4-fig1.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>1. Some experiments may need to be described in more detail&quot; e.g., ABH/Orange G staining, biomechanical testing, μCT analysis, et al.</p>
</disp-quote>
<p>Reply: Thanks for your comments. We have provided more information of experiment procedures.</p>
<disp-quote content-type="editor-comment">
<p>1. This study proposed that Col2-expressing cells play a key role in the progression of GONFH, did the authors use Col2+ cells for the in vitro experiments?</p>
</disp-quote>
<p>Reply: As in vitro experiments could not reflect the location of Col2-expressing cells in the femoral head, therefore here we applied in vivo lineage tracing study. After as long as 9 month of linage trace, we thoroughly showed the self-renew ability and osteogenic commitment of Col2+ cells, as well as its space variation in the femoral head with age. Conditional knockout of β-catenin caused that Col2+ cells trans-differentiated into adipogenic cells instead of osteogenic cells, which directly clarified the mechanism of Col2+ cells leading to GONFH-like phenotype in mice.</p>
<disp-quote content-type="editor-comment">
<p>1. A few typo errors, such as Line 13, &quot;contribute&quot; should be &quot;contributes&quot;; Line 118, &quot;reveled&quot; should be &quot;revealed&quot;.</p>
</disp-quote>
<p>Reply: We have revised the grammar errors in the new manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>In this manuscript, the authors reported a study to uncover that β-catenin inhibition disrupting the homeostasis of osteogenic/adipogenic differentiation contributes to the development of Glucocorticoid-induced osteonecrosis of the femoral head (GONFH). In this study, they first observed abnormal osteogenesis and adipogenesis associated with decreased β-catenin in the necrotic femoral head of GONFH patients, but the exact pathological mechanisms of GONFH remain unknown. They then performed in vivo and in vitro studies to further reveal that glucocorticoid exposure disrupted osteogenic/adipogenic differentiation of bone marrow stromal cells (BMSCs) by inhibiting β-catenin signaling in glucocorticoid-induced GONFH rats, and specific deletion of β-catenin in Col2+ cells shifted BMSCs commitment from osteoblasts to adipocytes, leading to a full spectrum of disease phenotype of GONFH in adult mice.</p>
<p>Strengths:</p>
<p>This innovative study provides strong evidence supporting that β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation that contributes to the development of GONFH. This study also identifies an ideal genetically modified mouse model of GONFH. Overall, the experiment is logically designed, the figures are clear, and the data generated from humans and animals is abundant supporting their conclusions.</p>
<p>Weaknesses:</p>
<p>There is a lack of discussion to explain how the Wnt agonist 1 works. There are several types of Wnt ligands. It is not clear if this agonist only targets Wnt1 or other Wnts as well. Also, why Wnt agonist 1 couldn't rescue the GONFH-like phenotype in β-cateninCol2ER mice needs to be discussed.</p>
</disp-quote>
<p>Reply: Thanks for your constructive comments. Wnt agonist 1 is a cell-permeating activator of the Wnt signaling pathway that induces transcriptional activity dependent on β-catenin (PMID: 25514428,18624906). In the present study, we aim to demonstrate that activation of β-catenin signaling could alleviate the phenotype of rat GONFH, thus only β-catenin and downstream targets (RUNX2, ALP, PPAR-γ, FABP4) expressions were detected after Wnt agonist 1 intervention. Conditional knockout β-catenin in Col2+ cells lead to an mouse GONFH-like phenotype. Wnt agonist 1 couldn't rescue this GONFH-like, as it did not activate β-catenin signaling. We have discussed them in the new version.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public Review):</bold></p>
<p>Summary:</p>
<p>In this manuscript, the authors are trying to delineate the mechanism underlying the osteonecrosis of the femoral head.</p>
<p>Strengths:</p>
<p>The authors provided compelling in vivo and in vitro data to demonstrate Col2+ cells and Osx+ cells were differentially expressed in the femoral head. Moreover, inducible knockout of β-catenin in Col2+ cells but not Osx+ cells lead to a GONFH-like phenotype including fat accumulation, subchondral bone destruction, and femoral head collapse, indicating that imbalance of osteogenic/adipogenic differentiation of Col2+ cells plays an important role in GONFH pathogenesis. Therefore, this manuscript provided mechanistic insights into osteonecrosis as well as potential therapeutic targets for disease treatment.</p>
<p>Weaknesses:</p>
<p>However, additional in-depth discussion regarding the phenotype observed in mice is highly encouraged.</p>
</disp-quote>
<p>Reply: Thanks for your comments. Inducible knockout of β-catenin in Col2+ cells but not Osx+ cells lead to a GONFH-like phenotype. Lineage tracing data showed Col2+ cells and Osx+ cells were different cell populations, and we have discussed the potential mechanism caused the different phenotypes between β-cateninCol2ER mice and β-cateninOsxER mice.</p>
<disp-quote content-type="editor-comment">
<p>1. Why did the authors use dexamethasone in the cellular experiments but methylprednisolone to induce the GONFH rat model?</p>
</disp-quote>
<p>Reply: Thanks for the comments. Here, we applied a dexamethasone (DEX)-treated BMSC model in vitro and a methylprednisolone (MPS)-induced rat model in vivo for GONFH study based on the published literatures (PMID: 37317020, 29662787, 29512684,35126710, 32835568).</p>
<disp-quote content-type="editor-comment">
<p>1. Both bone damage and fat accumulation were observed in 3-month-old and 6-month-old β-cateninCol2ER mice, but the femoral head collapse (the feature of GONFH at the late stage) only occurred in the older β-catenin Col2ER mice. This interesting observation needs to be discussed.
Reply: Thanks for the comments. Bone damage caused a poor mechanical support is the key to femoral head collapse. Despite of similar trabecular bone loss and fat accumulation in the 3-month-old and 6-month-old β-cateninCol2ER mice, the older mice also presented extensive subchondral bone destruction. Integrated subchondral bone provided a well mechanical support for femoral head morphology, therefore femoral head collapse were occurred in the older β-cateninCol2ER mice.</p>
<p>1. In the Materials and Methods, detailed information on the reagents should be provided.</p>
</disp-quote>
<p>Reply: We have provided detailed information of the important reagents.</p>
<disp-quote content-type="editor-comment">
<p>1. As shown in Figure 4, β-cateninOsxER mice at 3 months of age did not show differences in lipid droplet area and empty lacunae rate, but there was a decrease in bone area. The authors should at least provide some necessary discussion of this phenomenon.</p>
</disp-quote>
<p>Reply: Thanks for your comments. In the present study, we found few lipid droplet and empty lacuna but a significant decrease of bone mass in the femoral heads of β-cateninOsxER mice. Previous studies showed that specific knockout of β-catenin in Osx-expressing cells promoted osteoclast formation and activity, leading to the bone mass loss (PMID: 29124436, 34973494). We discussed this phenomenon in the new version.</p>
</body>
</sub-article>
</article>